Should I get a second opinion on my Multiple Myeloma diagnosis
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Getting a Second Opinion for Multiple Myeloma: A Smart Decision
Yes, getting a second opinion is strongly recommended—and it's a normal, important part of cancer care. In fact, the NCCN Guidelines for Patients emphasize this so clearly that they dedicate a specific section to it.
Why a Second Opinion Matters for Myeloma
According to the NCCN Guidelines for Patients: Multiple Myeloma, here's what you should know:
Treatment decisions made early can seriously affect your later options. This is especially true with myeloma because:
- Multiple myeloma has dozens of available treatment options, and the choice you make now influences what treatments remain available later
- Different specialists may recommend different approaches based on their experience
- Early treatment decisions (like whether to pursue a hematopoietic cell transplant) have long-term implications
Why Seek a Myeloma Specialist Specifically?
The NCCN Guidelines are very clear on this point:
"Seek out a myeloma specialist, if you can, because they have more experience diagnosing and treating people with this disease. Treatment decisions made by a non-myeloma specialist can seriously affect later treatment decisions."
A myeloma specialist has:
- Deeper experience with the nuances of this specific cancer
- Knowledge of the latest treatment combinations
- Better understanding of how to sequence treatments over time
- Familiarity with genetic testing results (FISH panel, TP53 mutations) that guide treatment
You Have Time
Here's reassuring news: Most people with myeloma have enough time to get a second opinion. You don't need to rush into treatment immediately. The NCCN Guidelines note that "there's usually enough time to have another cancer care provider review your test results and suggest a treatment plan."
What to Bring to Your Second Opinion
Make sure the second opinion provider has:
- Your complete pathology report (bone marrow biopsy results)
- Your FISH panel results (genetic testing of myeloma cells)
- Your imaging studies (PET/CT, MRI, or CT scans)
- Your lab results (M protein levels, free light chain assay, kidney function, etc.)
- Any TP53 mutation testing results
Questions to Ask During Your Second Opinion
- Do you agree with the diagnosis and staging?
- What is your recommended treatment plan, and why?
- How does this compare to other standard approaches?
- Am I a candidate for a hematopoietic cell transplant?
- What are the pros and cons of the treatments you're recommending?
- How will we monitor whether treatment is working?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Multiple Myeloma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Multiple Myeloma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
What is the life expectancy for multiple myeloma cancer
I understand this is one of the most important questions you might have. Let me share what the current medical evidence shows, while being clear about
What is the 5-year survival rate for multiple myeloma
I appreciate this important question, but I need to be transparent with you: the NCCN Guidelines for Patients materials I have access to don't include
What is the average survival rate for multiple myeloma by stage
I appreciate this important question. However, I need to be direct with you: the NCCN Guidelines for Patients that I have access to do not include spe